Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.
Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.
A qualitative study of surgeon-patient communication in the rectal cancer consultations,” published in the November 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results